Stalenhoef, A.F.

patient study level statin cholesterol change ldl-c plasma group treatment effect association subject carotid lipoprotein intima –media thickness lipid simvastatin trial disease therapy polymorphism result population atorvastatin thickness rlp-c rosuvastatin baseline haplotype normolipidemic fch patients reduction progression atherosclerosi family allele apoa 5 gene table type iii hlp apheresi analysis usf 1 normolipidemic relatives difference hyperlipidemia analyses torcetrapib tg levels statin therapy value event artery intima − 1131 t cimt change –media factor heart relative ldl apheresis hypercholesterolemia pravastatin cimt progression linkage apolipoprotein spouse model plasma rlp-c levels usf 1 gene insulin ezetimibe outcome concentration gender increase /liter goal attainment blood erasmu